Azul (NYSE:AZUL) reported quarterly losses of R$(0.08) per share. This is unchanged from the same period last year. The company reported R$4.38 billion in sales this quarter. This is a 61.04 percent increase over sales
Gainers
LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.